08.30

Opening of the virtual conference room

09.00

Welcome, introduction & logistical aspects
Dr. Thomas Heinz, Novartis


Session 1
Chair: Dr. René Wyler, Novartis Pharma AG

09.15

Dr. Stefanie Flohr & Dr. Philipp Lustenberger, Novartis
«LNP023 / iptacopan: Discovery and Synthesis Development of a First-in-Class, Oral Factor B Inhibitor for the Treatment of Rare Renal and Hematological Diseases»

09.45

Dr. Sarah Sulzer, Syngenta
«Sustainable Crop Protection Solutions»

10.15

2x Short Lectures

Dr. Marc Liniger, Givaudan
«A Sea Breeze of Novel Fragrant Indanyl Aldehydes»

Dr. Vijay Pattabiraman, Bright Peak Therapeutics

10.45

Break


Session 2
Chair: Dr. Heyley Binch, F. Hoffmann-La Roche Ltd

11.00

Dr. Jonathan Medlock, DSM
«New Routes to Old Molecules: Improving the Synthesis of some Water Soluble Vitamins»

11.30

2x Short Lectures

Dr. Steffen Eller, Chemspeed
«Gamification of Research & Development»

Dr. Florian Bächle, Solvias
«The Power of Applied Chemocatalysis»

12.00

Lunch Break,Virtual Poster Session

13.50

Welcome, Introduction & logistical aspects


Session 3
Chair: Prof. Olivier Baudoin, University of Basel

14.00

Dr. Cornelia Zumbrunn, Idorsia
«Antibacterial drug discovery today: more than “just” scientific challenges.
The discovery of topoisomerase inhibitor ACT-452051»

14.30

3x short lectures

Dr. Francesco Santoro, Firmenich
«Process Research and Industrialization of a powerful coconut-scented fragrance ingredient using safe and economical Hydroboration and Homogeneous Catalytic Dehydrogenation»

Dr. Thierry Jousseaume, Johnson&Johnson
«Asymmetric Synthesis of Esketamine»

Dr. Radka Snajdrova, Novartis
«Discovery and applications of enzymes in the synthesis of drugs and drug candidates»

15.15

Break


Session 4
Chair: Dr. Jérôme Cassayre, Syngenta Crop Protection AG

15.30

Dr. Fabienne Hoffmann-Emery, Roche
«A Greener Process for the DLK Inhibitor GDC-0134»

16.00

Dr. Reto Naef, Topadur
«NO to aging and cancer»

16.30

SusChem Switzerland: Organization, Strategy and Focus Topics
Dr. Maud Reiter, Firmenich and Dr. Edouard Godineau, Syngenta

16.45

Ceremony Best Presentation Award
Dr. Fabrice Gallou, Novartis Pharma AG
Dr. Richard Smith, Helvetica

17.00

Closing remark
Dr. Alain De Mesmaeker, President of the Swiss Chemical Society